Termination of protein synthesis occurs when a translating ribosome encounters one of three universally conserved stop codons: UAA, UAG or UGA. Release factors recognize stop codons in the ribosomal A-site to mediate release of the nascent chain and recycling of the ribosome. Bacteria decode stop codons using two separate release factors with differing specificities for the second and third bases 1 . By contrast, eukaryotes rely on an evolutionarily unrelated omnipotent release factor (eRF1) to recognize all three stop codons 2 . The molecular basis of eRF1 discrimination for stop codons over sense codons is not known. Here we present cryoelectron microscopy (cryo-EM) structures at 3.5-3.8 Å resolution of mammalian ribosomal complexes containing eRF1 interacting with each of the three stop codons in the A-site. Binding of eRF1 flips nucleotide A1825 of 18S ribosomal RNA so that it stacks on the second and third stop codon bases. This configuration pulls the fourth position base into the A-site, where it is stabilized by stacking against G626 of 18S rRNA. Thus, eRF1 exploits two rRNA nucleotides also used during transfer RNA selection to drive messenger RNA compaction. In this compacted mRNA conformation, stop codons are favoured by a hydrogen-bonding network formed between rRNA and essential eRF1 residues that constrains the identity of the bases. These results provide a molecular framework for eukaryotic stop codon recognition and have implications for future studies on the mechanisms of canonical and premature translation termination 3,4 . Termination of translation in eukaryotes is initiated when a ternary complex of eRF1-eRF3-GTP binds to a stop codon in the ribosomal A-site 5, 6 . GTP hydrolysis by eRF3 induces a conformational change that leads to its dissociation, permitting eRF1 to accommodate fully in the A-site. This change is thought to bring a universally conserved GGQ motif close to the ester bond between the nascent polypeptide and the tRNA, stimulating its hydrolysis. Concomitant with these events, the ATPase ABCE1 is recruited to the ribosome after eRF3 dissociation and, together with eRF1, catalyses splitting of the ribosomal subunits to recycle post-termination complexes 3,4, 7, 8 . We reasoned that a catalytically inactive eRF1 mutant may trap a pre-hydrolysis termination complex with two key features. First, eRF1 would be in complex with the stop codon it had recognized. Second, the unreleased nascent polypeptide would provide a unique affinity handle to enrich this species for structural analysis. Therefore, we substituted the glycines of the GGQ motif with alanines (eRF1(AAQ)) 9 and added this mutant to in vitro translation reactions in rabbit reticulocyte lysate. Peptide release at all three stop codons was inhibited by eRF1(AAQ) as judged by persistence of a peptidyl-tRNA (Extended Data Fig. 1a, b) . Affinity purification of these ribosomenascent chain complexes (RNCs) via the nascent chain recovered both eRF1(AAQ) and ABCE1 (Extended Data Fig. 1c, d ), suggesting that eRF1(AAQ) was trapped on the RNCs in its accommodated state. Association of ABCE1 was enhanced with eRF1(AAQ)-stalled RNCs relative to RNCs stalled with a truncated mRNA (Extended Data Fig.  1c ), consistent with a report that the function of ABCE1 in post-termination recycling requires peptidyl-tRNA hydrolysis 7 . Purified RNCs stalled with eRF1(AAQ) at each stop codon (Extended Data Fig. 1d ) were directly used for cryo-EM. Multiple rounds of three-dimensional classification in silico revealed that ,10% of the particles contained eRF1(AAQ)-ABCE1 (Extended Data Fig. 2 ).
Termination of protein synthesis occurs when a translating ribosome encounters one of three universally conserved stop codons: UAA, UAG or UGA. Release factors recognize stop codons in the ribosomal A-site to mediate release of the nascent chain and recycling of the ribosome. Bacteria decode stop codons using two separate release factors with differing specificities for the second and third bases 1 . By contrast, eukaryotes rely on an evolutionarily unrelated omnipotent release factor (eRF1) to recognize all three stop codons 2 . The molecular basis of eRF1 discrimination for stop codons over sense codons is not known. Here we present cryoelectron microscopy (cryo-EM) structures at 3.5-3.8 Å resolution of mammalian ribosomal complexes containing eRF1 interacting with each of the three stop codons in the A-site. Binding of eRF1 flips nucleotide A1825 of 18S ribosomal RNA so that it stacks on the second and third stop codon bases. This configuration pulls the fourth position base into the A-site, where it is stabilized by stacking against G626 of 18S rRNA. Thus, eRF1 exploits two rRNA nucleotides also used during transfer RNA selection to drive messenger RNA compaction. In this compacted mRNA conformation, stop codons are favoured by a hydrogen-bonding network formed between rRNA and essential eRF1 residues that constrains the identity of the bases. These results provide a molecular framework for eukaryotic stop codon recognition and have implications for future studies on the mechanisms of canonical and premature translation termination 3, 4 . Termination of translation in eukaryotes is initiated when a ternary complex of eRF1-eRF3-GTP binds to a stop codon in the ribosomal A-site 5, 6 . GTP hydrolysis by eRF3 induces a conformational change that leads to its dissociation, permitting eRF1 to accommodate fully in the A-site. This change is thought to bring a universally conserved GGQ motif close to the ester bond between the nascent polypeptide and the tRNA, stimulating its hydrolysis. Concomitant with these events, the ATPase ABCE1 is recruited to the ribosome after eRF3 dissociation and, together with eRF1, catalyses splitting of the ribosomal subunits to recycle post-termination complexes 3, 4, 7, 8 . We reasoned that a catalytically inactive eRF1 mutant may trap a pre-hydrolysis termination complex with two key features. First, eRF1 would be in complex with the stop codon it had recognized. Second, the unreleased nascent polypeptide would provide a unique affinity handle to enrich this species for structural analysis. Therefore, we substituted the glycines of the GGQ motif with alanines (eRF1(AAQ)) 9 and added this mutant to in vitro translation reactions in rabbit reticulocyte lysate. Peptide release at all three stop codons was inhibited by eRF1(AAQ) as judged by persistence of a peptidyl-tRNA (Extended Data Fig. 1a, b) . Affinity purification of these ribosomenascent chain complexes (RNCs) via the nascent chain recovered both eRF1(AAQ) and ABCE1 (Extended Data Fig. 1c, d ), suggesting that eRF1(AAQ) was trapped on the RNCs in its accommodated state. Association of ABCE1 was enhanced with eRF1(AAQ)-stalled RNCs relative to RNCs stalled with a truncated mRNA (Extended Data Fig.  1c ), consistent with a report that the function of ABCE1 in post-termination recycling requires peptidyl-tRNA hydrolysis 7 . Purified RNCs stalled with eRF1(AAQ) at each stop codon (Extended Data Fig. 1d ) were directly used for cryo-EM. Multiple rounds of three-dimensional classification in silico revealed that ,10% of the particles contained eRF1(AAQ)-ABCE1 (Extended Data Fig. 2 ). complex. a, Overview of the eRF1(AAQ)-stalled mammalian ribosomenascent chain complex containing the UAG stop codon. Displayed are the 40S and 60S ribosomal subunits, E-and P-site tRNAs, eRF1(AAQ) occupying the A-site, and ABCE1 occupying the GTPase centre. b, Close-up view of eRF1(AAQ) coloured by domain (N, M, C) with the GGQ, NIKS and YxCxxxF motifs highlighted (pink). Also shown are the P-site tRNA, nascent polypeptide, the mRNA containing the UAG stop codon, and ABCE1 with its iron-sulfur clusters and nucleotide-binding sites indicated.
Data sets of between 20,000 and 50,000 particles for the three stop codons yielded maps with overall resolutions of 3.65 Å (UAA), 3.45 Å (UAG) and 3.83 Å (UGA), against which the models were refined (Fig. 1 , Extended Data Fig. 3 and Extended Data Table 1) .
In each reconstruction, eRF1 is in its extended conformation 10 , and ABCE1 occupies the GTPase centre (Fig. 1a) . The three domains of eRF1 (N, M and C) have moved relative to one another compared to the crystal structure 11 (Extended Data Fig. 4a ) and are each well resolved (Extended Data Fig. 3b ). Direct interactions of the N domain with the codon deep in the decoding centre argues against an earlier suggestion that eRF1 disengages from the stop codon in the presence of ABCE1 (ref. 10) .
The N and M domains of eRF1 independently contact the P-site tRNA and together structurally resemble a tRNA in the A-site (Fig. 1b) . Helix a2 of the N domain runs parallel to, and interacts with, the anticodon stem-loop of the P-site tRNA (Extended Data Fig. 4b ). The M domain is functionally analogous to the tRNA acceptor stem 11 , and positions the GGQ motif 9 in the peptidyl transferase centre (Fig. 1b) . To occupy a similar position as the 39 end of an A-site tRNA, the GGQ-loop is shifted by 10 Å compared to the crystal structure 11 (Extended Data Fig. 4c ). This positions the alanine residues of the mutated GGQ motif directly opposite the terminal 39 adenosine of the P-site tRNA and the glutamine (Gln185) in proximity to the ester bond between the nascent polypeptide and the tRNA. This conformation closely resembles that of the GGQ-loop in bacterial release factors [12] [13] [14] (Fig. 2a) . At the decoding centre, the interactions between the N domain of eRF1 and the stop codon are well resolved (Fig. 2b and Extended Data  Fig. 5 ). The most striking feature is a compact configuration of mRNA that accommodates four nucleotides in the A-site instead of three (Fig. 3a, b) . mRNA compaction depends crucially on the 'flipping out' of A1825 (A1493 in bacteria) in helix 44 (h44) of 18S rRNA, forming a stacking interaction with the 12 nucleotide of the stop codon, on which the 13 nucleotide stacks. This configuration allows the 14 nucleotide to stack with base G626 (G530 in bacteria) of 18S rRNA (Fig. 3b) . Stacking with G626 would be more stable for purines, explaining their statistical bias at the 14 position in eukaryotes 15 . Compaction of mRNA in the A-site probably results in pulling downstream mRNA further into the mRNA channel. This is consistent with protection of two additional nucleotides of 39 mRNA upon eRF1 binding to the ribosome 16, 17 . The structures of the bacterial release factor complexes are qualitatively distinct (Fig. 3c) . Instead of A1493, the adjacent A1492 is flipped out [12] [13] [14] . However, this flipped base does not stack with any of the stop codon bases and does not lead to mRNA compaction. G530 therefore stacks with the 13 base of the stop codon [12] [13] [14] instead of the 14 base. While the 14 base also affects stop codon recognition in bacteria, the greatest preference seems to be for uridine rather than for purines 18 . Thus, eukaryotes seem to exploit the 14 base to stabilize mRNA compaction. The unique stacking of the 12 and 13 bases in this compacted state is an important element for stop codon recognition by eRF1 (see below).
The conserved NIKS, YxCxxxF and GTS motifs in eRF1 have been crosslinked to stop codon bases 19, 20 . In the structures here, the essential NIKS sequence (residues 61-64) 21 , located at the end of helix a2, imposes a requirement for uridine in the first (11) position via interactions with its Watson-Crick edge. A local distortion in helix a2 and the subsequent loop helps to optimise hydrogen-bond interactions with the nucleotide (Fig. 4a) ) of the mRNA in each termination complex reveal the same compacted conformation. The P-site Val GUU codon and the stop codon (11 to 13) and following base (14) in the A-site are indicated. b, eRF1(AAQ) (purple) recognizes four mRNA bases (11 to 14, slate) in the A-site. Bases 12 and 13 stack on A1825, which is flipped out of helix 44 (h44), and base 14 on G626 of 18S rRNA. c, In bacteria, RF1 (grey) recognizes a more extended stop codon configuration where the 13 base stacks on G530 (the equivalent of G626) of 16S rRNA.
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Purines would be disfavoured at the 11 position by steric hindrance with eRF1, while cytidine would be incompatible with the hydrogenbonding requirements of the NIKS motif (Extended Data Fig. 6 ). Thus, the universality of uridine in the first position of stop codons is defined by extensive hydrogen bonding with eRF1. In bacteria, RF1 and RF2 also utilize hydrogen-bonding networks to specify uridine in the 11 position, but with different interactions 12 , highlighting how independent solutions have evolved for the same specificity problem.
Interactions of the YxCxxxF motif and Glu55 of eRF1 with the 12 and 13 purines provide a basis for stop codon discrimination from sense codons (Fig. 4b, c) . The main chain of Cys127 from the YxCxxxF motif can form two hydrogen bonds with the Watson-Crick edge of A1825 to stabilize its flipped orientation, facilitating stacking of the 12 and 13 bases (Fig. 4b) . The invariant residues Glu55 from helix a2 and Tyr125 may act as a pair 23 to position the glutamate side chain so that it can hydrogen bond with the N6 atoms of adenosines at the 12 and/or 13 positions. These interactions are only possible with purines, excluding pyrimidines from the 12 and 13 positions in stop codons. In the case of UGG, which codes for tryptophan, the two O6 atoms of consecutive stacked guanosines would not satisfy the hydrogen-bonding requirements, and their increased repulsion with each other and with the negatively-charged Glu55 would also disfavour the formation of the conformation that allows these interactions (Fig. 4c) .
The conserved GTS motif, located towards the sugar edge of the 13 base, adopts two different conformations that are interdependent with the position of the YxCxxxF motif 24 . With adenosine in the 12 position, Thr32 faces the 13 base and can hydrogen bond with the N2 atom of the guanosine in UAG (Fig. 4b) . A guanosine at the 12 position is accommodated by a movement of the YxCxxxF motif towards the stacked pair by ,1 Å , which propagates a 4 Å movement of the GTS motif so that Thr32 now faces away from the stop codon (Fig. 4d) . Consistent with these observations, perturbation of any residue contributing to this network has substantial effects on stop codon recognition and specificity 17, 23, 25, 26 .
In conclusion, these structures show how stop codons are specifically selected by eRF1. At the 11 position, only uridine can form the network of interactions with the NIKS motif. The flipping of A1825 results in its stacking onto the 12 and 13 bases of a distorted mRNA so that they are decoded as a single unit (Fig. 4b) . This solves the puzzle of how guanosine can occur at either the 12 or 13 position but not at both: two successive guanosines would lead to repulsion between their O6 atoms and with Glu55 (Fig. 4c) . By requiring two purines while specifically excluding consecutive guanosines, the selectivity of eRF1 at the 12 and 13 positions is logically equivalent to a NAND gate.
This mechanism for stop codon recognition by eRF1 is distinct from that used by the evolutionarily and structurally unrelated bacterial release factors, even though they share some common strategies including the extensive use of hydrogen bonding for decoding specificity and an invariant GGQ motif to catalyse peptide hydrolysis. The work here paves the way for studies on the mechanism of termination and ribosome recycling, including the roles of eRF3 and ABCE1, as well as the interaction of termination factors with quality control pathways such as nonsense-mediated mRNA decay 27 . Finally, insight into stop codon recognition can provide a framework for the development of inhibitors of termination that may be useful to treat the ,11% of hereditary diseases caused by premature termination 28, 29 .
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METHODS
No statistical methods were used to predetermine sample size and the experiments were not randomized. Plasmids and antibodies. An SP64-based plasmid encoding 3 3 Flag-tagged Sec61b containing the autonomously-folding villin headpiece (VHP) domain 30 was modified by individually inserting each stop codon (TAA, TAG, TGA) after the valine at position 68 of unmodified Sec61b. The remaining carboxy-terminal portion of the protein was deleted using Phusion mutagenesis (Thermo Scientific).
In vitro transcription reactions were performed using PCR products generated with primers flanking the SP6 promoter and the 39 UTR of the SP64 vector as previously described 31 . The complementary DNA encoding human eRF1 (Origene) was subcloned into a pRSETA expression vector after an aminoterminal 6 3 His tag and tobacco etch virus (TEV) cleavage site using standard procedures. The eRF1(AAQ) mutant was generated via Phusion mutagenesis. Antibodies against Hbs1 and ABCE1 have been described 32 ; the eRF1 antibody was from New England Biolabs. Release factor purification. Wild-type and mutant eRF1 (eRF1(AAQ)) were expressed in and purified from Escherichia coli BL21(DE3) cells grown under antibiotic selection in LB. Transformed cells were induced at A 600 nm 5 0.4-0.6 with 0.2 mM IPTG for 2 h at 37 uC and lysed with a microfluidiser in lysis buffer (1 3 PBS, pH 7.5, 250 mM NaCl, 10 mM imidazole, 1 mM DTT) containing 1 3 protease inhibitor cocktail (Roche). Lysates were clarified by centrifugation and the supernatant passed over a NiNTA column. After washing with 25 column volumes of lysis buffer, elutions were carried out with 250 mM imidazole in lysis buffer. Peak fractions were pooled, dialysed overnight in the presence of TEV protease against 50 mM HEPES, pH 7.4, 150 mM potassium acetate, 5 mM magnesium diacetate, 10 mM imidazole, 10% glycerol, 1 mM DTT. The TEV protease and cleaved His tag were removed by passage over a NiNTA column.
In vitro translations and sample preparation. In vitro translations in a rabbit reticulocyte (RRL) system were for 25 min at 32 uC as described previously 30, 31 . Where indicated, 0.5 mM eRF1(AAQ) was included to trap termination complexes. 4 ml translation reactions were directly incubated with 100 ml (packed volume) of anti-Flag M2 beads (Sigma) for 1-1.5 h at 4 uC with gentle mixing. The beads were washed sequentially with 6 ml of 50 mM HEPES, pH 7.4, 100 mM potassium acetate, 5 mM magnesium diacetate, 0.1% Triton X-100, 1 mM DTT, 6 ml of 50 mM HEPES, pH 7.4, 250 mM potassium acetate, 5 mM magnesium diacetate, 0.5% Triton X-100, 1 mM DTT and 6 ml of RNC buffer (50 mM HEPES, pH 7.4, 100 mM potassium acetate, 5 mM magnesium diacetate, 1 mM DTT). Two sequential elutions were carried out with 100 ml 0.1 mg ml 21 3 3 Flag peptide (Sigma) in RNC buffer at room temperature for 25 min. The elutions were combined and centrifuged at 100,000 rpm at 4 uC for 40 min in a TLA120.2 rotor (Beckman Coulter) before resuspension of the ribosomal pellet in RNC buffer. Electron microscopy. 3 ml aliquots of purified ribosome complexes at a concentration of 120 nM were applied onto Quantifoil R2/2 cryo-EM grids covered with continuous carbon (estimated to be 50 Å thick) at 4 uC and 100% ambient humidity. After 30 s incubation, the grids were blotted for 3 s and vitrified in liquid ethane using a Vitrobot MKIII (FEI).
Automated data collection (EPU software, FEI) was conducted on a Titan Krios microscope equipped with a XFEG electron source using 300 kV acceleration voltage. For each 1.1 s exposure, 17 movie frames were recorded on a Falcon II direct electron detector (FEI) at a calibrated magnification of 104,478, resulting in a pixel size of 1.34 Å (ref. 33) . A dose rate of ,30 electrons per Å 2 per second was used. Defocus values ranged from 21.1 to 25.9 mm for the UAA-eRF1(AAQ) data set, 20.7 to 24.1 mm for the UAG-eRF1(AAQ) data set, and 20.7 to 23.8 mm for the UGA-eRF1(AAQ) data set (Extended Data Table 1 ), as more images were collected closer to focus on the latter two data sets. Image processing. The 17 frames were aligned using whole-image motion correction 34 to reduce beam-induced blurring of the images. Parameters of the contrast transfer function for each motion-corrected micrograph were obtained using Gctf (K. Zhang (kzhang@mrc-lmb.cam.ac.uk), MRC-LMB, in development). Ribosome particles were selected using semi-automated particle picking implemented in RELION 35 . All two-and three-dimensional classifications and refinements were performed using RELION 36 . We used reference-free two-dimensional class averaging to discard non-ribosomal particles and three-dimensional classification to sort different compositions and conformations of the ribosome complexes. After two-dimensional classification, the UAA-eRF1(AAQ) data set contained 556,994 particles from two independent data acquisitions, while the UAG-eRF1(AAQ) and UGA-eRF1(AAQ) data sets contained 216,276 and 250,705 particles, respectively, both from a single data acquisition.
A 40 Å low-pass filtered cryo-EM reconstruction of the rabbit 80S ribosome (Electron Microscopy Data Bank (EMDB) accession 2704) 32 was used as an initial model for the three-dimensional refinement. In a subsequent three-dimensional classification run with 12 classes, an angular sampling of 1.8u was combined with local angular searches, and the refined model from the first refinement was used as a starting model. A further round of refinement and three-dimensional classification into 6 classes using an angular sampling of 0.9u combined with local angular searches was necessary to isolate a homogeneous class of ribosomes bound with eRF1-ABCE1 (see Extended Data Fig. 2 ). This resulted in 49,979 particles for the UAA-eRF1(AAQ) data set, 20,515 particles for the UAG-eRF1(AAQ) data set, and 22,058 particles for the UGA-eRF1(AAQ) data set.
Prior to a final round of refinement and classification with classes combined from different data sets, statistical particle-based movie correction was performed in RELION-1.4. For these calculations we used running averages of five movie frames, and a standard deviation of one pixel for the translational alignment. In addition, we used a resolution and dose-dependent model for the radiation damage, in which each frame is B-factor weighted as estimated from single-frame reconstructions 37 . Reported resolutions are based on the Fourier shell correlation (FSC) 0.143 criterion. High-resolution noise substitution was used to correct for the effects of a soft mask on FSC curves 38 . Before visualization, density maps were corrected for the modulation transfer function of the Falcon II detector and then sharpened by applying a negative B-factor that was estimated using automated procedures 39 (Extended Data Table 1 ). Local resolution was quantified using ResMap 40 .
Model building. The reconstruction was initially interpreted by docking the large and small subunits of the mammalian 80S ribosome, with respective Protein Data Bank (PDB) accession codes 3J92 and 3J7P 41, 42 , into the map using Chimera 43 . The crystal structures of human eRF1 (PDB accession code 1DT9) 11 and Pyrococcus abysii ABCE1 (PDB accession code 3BK7) 44 were docked into the A-site and GTPase centre, respectively, before being subjected to a Jiggle Fit in Coot 45 .
To model the bound tRNAs, bacterial tRNA (PDB accession code 4V51) 46 was used as a template and modified to the sequence of the most prevalent tRNA for the particular codon from the genomic tRNA database 47 . The atomic models were then modified in Coot v0.8 to agree with the rabbit sequences and optimized for fit to density. Model refinement and validation. Reciprocal space refinement was carried out in REFMAC v5.8 optimized for electron microscopy maps using external restraints generated by ProSMART and LIBG 45 . The model was refined against amplitudes and phases from the experimental map that were unchanged during the course of refinement. FSC average was monitored during refinement to follow the fit-todensity, and the final model was validated using MolProbity 48 (Extended Data Table 1 ). The Ramachandran statistics for eRF1 are 93.0% favoured, 1.5% outliers and for ABCE1, 91.1% favoured, 1.9% outliers. Cross-validation against overfitting was calculated as previously described 45, 49 (Extended Data Fig. 3c ).
Extended Data Figure 2 | In silico 3D classification scheme for cryo-EM data sets. Particles extracted from automated particle picking in RELION were subjected to 2D classification. Non-ribosomal particles were discarded and the remaining particles were combined for a 3D refinement. The resulting map was used as a reference for 3D classification, which typically isolated 5 distinct classes of ribosomal complexes with the indicated distributions. Classes containing 80S ribosomes with canonical P-and E-site tRNAs and weak factor density in the A-site (,40%) were combined and subjected to another round of 3D classification for A-site occupancy. Approximately one-third of this population contained strong density for eRF1(AAQ) and ABCE1. These particles were combined for subsequent 3D refinement and movie processing. All four data sets (two for the UAA stop codon and one each for the UAG and UGA stop codons) were processed similarly. The eRF1(AAQ)-ABCE1-containing particles of the two UAA data sets after the two rounds of classification were combined for refinement to yield the final map.
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